HIV-2/SIV viral protein X counteracts HUSH repressor complex

Nature Microbiology

Volumn 3, Issue 8, 2018, Pages 891-897

  Chougui, Ghina ^a,b,c   Munir Matloob, Soundasse ^a,b,c   Matkovic, Roy ^a,b,c   Martin, Michaël M ^a,b,c   Morel, Marina ^a,b,c   Lahouassa, Hichem ^a,b,c   Leduc, Marjorie ^a,b,c   Ramirez, Bertha Cecilia ^a,b,c   Etienne, Lucie ^d,e   Margottin Goguet, Florence ^a,b,c  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^e UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; DCAF1 PROTEIN; DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1; HUMAN SILENCING HUB REPRESSOR COMPLEX PROTEIN; LIGASE; M PHASE PHOSPHOPROTEIN 8; MPP8 PROTEIN; MUTANT PROTEIN; PERIPHILIN; PROTEASOME; REPRESSOR PROTEIN; TRANSGENE ACTIVATION SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRAL PROTEIN; VIRAL PROTEIN X; VPR PROTEIN; MPP8 PROTEIN, HUMAN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; PPHLN1 PROTEIN, HUMAN; TASOR PROTEIN, HUMAN; TUMOR ANTIGEN; VPX PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 2; VPX PROTEIN, SIMIAN IMMUNODEFICIENCY VIRUS;

CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHLOROCEBUS AETHIOPS; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; GENE FUNCTION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; LENTIVIRUS; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOMICS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REACTIVATION; VPR GENE; VPX GENE; CELL LINE; GENE EXPRESSION REGULATION; HEK293 CELL LINE; HELA CELL LINE; HOST PATHOGEN INTERACTION; JURKAT CELL LINE; METABOLISM; PHYSIOLOGY; PRIMATE LENTIVIRUS; PROCEDURES; PROVIRUS; THP-1 CELL LINE;

ANTIGENS, NEOPLASM; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION; HEK293 CELLS; HELA CELLS; HIV-2; HOST-PATHOGEN INTERACTIONS; HUMANS; JURKAT CELLS; LENTIVIRUSES, PRIMATE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEOMICS; PROVIRUSES; SIMIAN IMMUNODEFICIENCY VIRUS; THP-1 CELLS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 85048312143     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/s41564-018-0179-6     Document Type: Letter

References (39)

1. Hrecka, K. et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658–661 (2011).
2. Laguette, N. et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654–657 (2011).
3. Tchasovnikarova, I. A. et al. Gene silencing. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells. Science 348, 1481–1485 (2015).
4. Matheron, S. et al. Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS 17, 2593–2601 (2003).
5. Saleh, S., Vranckx, L., Gijsbers, R., Christ, F. & Debyser, Z. Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection. J. Virus Erad. 3, 7–14 (2017).
6. Yu, X. F., Yu, Q. C., Essex, M. & Lee, T. H. The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage. J. Virol. 65, 5088–5091 (1991).
7. Guyader, M., Emerman, M., Montagnier, L. & Peden, K. VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J. 8, 1169–1175 (1989).
8. Schaller, T., Bauby, H., Hue, S., Malim, M. H. & Goujon, C. New insights into an X-traordinary viral protein. Front. Microbiol. 5, 126 (2014).
9. Baldauf, H. M. et al. Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells. Proc. Natl Acad. Sci. USA 114, 2729–2734 (2017).
10. Fujita, M., Nomaguchi, M., Adachi, A. & Otsuka, M. SAMHD1-dependent and -independent functions of HIV-2/SIV Vpx protein. Front. Microbiol. 3, 297 (2012).
11. Lahouassa, H. et al. HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. Proc. Natl Acad. Sci. USA 113, 5311–5316 (2016).
12. Liu, L. et al. A whole genome screen for HIV restriction factors. Retrovirology 8, 94 (2011).
13. Liu, N.et al. Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators. Nature 553, 228–232 2018.
14. Le Rouzic, E. et al. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 6, 182–188 (2007).
15. Jordan, A., Bisgrove, D. & Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868–1877 (2003).
16. Romani, B. et al. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin. Sci. Rep. 6, 31924 (2016).
17. Lim, E. S. et al. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe. 11, 194–204 (2012).
18. Daugherty, M. D. & Malik, H. S. Rules of engagement: molecular insights from host–virus arms races. Annu. Rev. Genet. 46, 677–700 (2012).
19. Duggal, N. K. & Emerman, M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat. Rev. Immunol. 12, 687–695 (2012).
20. Chen, H. C., Martinez, J. P., Zorita, E., Meyerhans, A. & Filion, G. J. Position effects influence HIV latency reversal. Nat. Struct. Mol. Biol. 24, 47–54 (2017).
21. Gramberg, T., Sunseri, N. & Landau, N. R. Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. J. Virol. 84, 1387–1396 (2010).
22. Goujon, C. et al. With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). Gene Ther. 13, 991–994 (2006).
23. Ueno, F. et al. Vpx and Vpr proteins of HIV-2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells. Microbes Infect. 5, 387–395 (2003).
24. Bergamaschi, A. et al. The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J. Virol. 83, 4854–4860 (2009).
25. Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214–217 (2010).
26. Gerard, A. et al. The integrase cofactor LEDGF/p75 associates with Iws1 and Spt6 for postintegration silencing of HIV-1 gene expression in latently infected cells. Cell Host Microbe 17, 107–117 (2015).
27. Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797 (2004).
28. Huh, J. W. et al. Molecular evolution of the periphilin gene in relation to human endogenous retrovirus m element. J. Mol. Evol. 62, 730–737 (2006).
29. Loytynoja, A. & Goldman, N. Phylogeny-aware gap placement prevents errors in sequence alignment and evolutionary analysis. Science 320, 1632–1635 (2008).
30. Kosakovsky Pond, S. L., Posada, D., Gravenor, M. B., Woelk, C. H. & Frost, S. D. Automated phylogenetic detection of recombination using a genetic algorithm. Mol. Biol. Evol. 23, 1891–1901 (2006).
31. Guindon, S. et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59, 307–321 (2010).
32. Pond, S. L., Frost, S. D. & Muse, S. V. HyPhy: hypothesis testing using phylogenies. Bioinformatics 21, 676–679 (2005).
33. Yang, Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 24, 1586–1591 (2007).
34. Gueguen, L. et al. Bio++: efficient extensible libraries and tools for computational molecular evolution. Mol. Biol. Evol. 30, 1745–1750 (2013).
35. Murrell, B. et al. Gene-wide identification of episodic selection. Mol. Biol. Evol. 32, 1365–1371 (2015).
36. Guegen, L. & Duret, L. Unbiased estimate of synonymous and non-synonymous substitution rates with non-stationary base composition. Mol. Biol. Evol. 35, 734–742 (2017).
37. Murrell, B. et al. FUBAR: a fast, unconstrained bayesian approximation for inferring selection. Mol. Biol. Evol. 30, 1196–1205 (2013).
38. Bell, S. M. & Bedford, T. Modern-day SIV viral diversity generated by extensive recombination and cross-species transmission. PLoS Pathog. 13, e1006466 (2017).
39. Gifford, R. J. et al. A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. Proc. Natl Acad. Sci. USA 105, 20362–20367 (2008).